Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05094271 · ClinicalTrials.gov registry record · Phase 1
Is Obstructive Sleep Apnea Important in the Development of Alzheimer's Disease?
A Phase 1 study of Alzheimer Disease and Obstructive Sleep Apnea, sponsored by University of California, San Diego.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 260
- Enrollment target
- 1
- Study location
NCT05094271 is a Phase 1 study of Alzheimer Disease and Obstructive Sleep Apnea that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 260 participants, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05094271, a Phase 1 study of Alzheimer Disease and Obstructive Sleep Apnea, is actively recruiting participants, sponsored by University of California, San Diego.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 260 participants
- Enrollment target
- 1
- Study location
Study Summary
Obstructive sleep apnea (OSA) is common in older adults and has recently been implicated in pathogenesis of Alzheimer's disease (AD). Research has shown that sleep disruptions have caused memory impairment. Sleep apnea is a form of sleep disruption. We would like to examine how obstructive sleep apnea may contribute to the progression of Alzheimer's disease.
Conditions Studied
Interventions
- OTHER Supplemental Oxygen
- DEVICE Continuous Positive Airway Pressure Machine
- OTHER Room Air
Study Locations (1)
California
- UCSD Sleep Research - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2021-06-30 |
| Est. Completion | 2025-05-20 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05094271
The ClinicalTrials.gov registry entry for NCT05094271 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 260 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (91% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 3 interventions - of which Supplemental Oxygen is the first listed.
NCT05094271 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05094271 about?
NCT05094271 is a clinical study titled "Is Obstructive Sleep Apnea Important in the Development of Alzheimer's Disease?". Obstructive sleep apnea (OSA) is common in older adults and has recently been implicated in pathogenesis of Alzheimer's disease (AD). Research has shown that sleep disruptions have caused memory impairment. Sleep apnea is a form of sleep disruption. We would like to examine how obstructive sleep apn...
What is the current status of trial NCT05094271?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 260 participants. The study started on 2021-06-30. Estimated completion is 2025-05-20.
What conditions does trial NCT05094271 study?
This clinical trial studies the following conditions: Alzheimer Disease, Obstructive Sleep Apnea, Sleep Apnea, OSA.
What interventions are being tested in trial NCT05094271?
The interventions under investigation include: Supplemental Oxygen (OTHER), Continuous Positive Airway Pressure Machine (DEVICE), Room Air (OTHER).
Who is sponsoring clinical trial NCT05094271?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05094271 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimer Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Autologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Directly Into the Brain for Mild to Moderate Alzheimer's Disease
RECRUITING · Phase 1
-
Study to Evaluate the Relative Bioavailability of a New Formulation of NPT 2042 Soft-Gelatin Capsules Compared to the Original Formulation of NPT 2042
RECRUITING · Phase 1
-
Nicotinic Acid for the Treatment of Alzheimer's Disease
RECRUITING · Phase 1
-
A Phase Ia/Ib, First-in-human (FIH) Study for Safety, Tolerability, Pharmacokinetics (PK), and Clinical Activity Evaluation of ADEL-Y01
RECRUITING · Phase 1
-
Deep Repetitive Transcranial Magnetic Stimulation (rTMS) of the Precuneus for Alzheimer Disease (AD)
RECRUITING · Phase 1
-
Assess Fibrin in Brains With AD/ADRD
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.